Catherine Callaghan Coombs , MD, MS - HealthTree Marginal Zone Lymphoma Directory
[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Clinical Expertise

  • Chronic myeloid leukemia
  • Myelodysplastic syndromes

About

Dr. Coombs’s research interests center on the application of genomic correlates to improve the clinical care of patients with leukemia. She has performed research to better understand the genetic risk factors leading to the development of chronic lymphocytic leukemia. Additionally, she has characterized a large cohort of solid tumor patients in whom clonal hematopoiesis has been identified on “matched normal” blood sequencing data obtained on next-generation sequencing to assess for associations between clonal hematopoiesis, prior cytotoxic therapy, and impact on long term outcomes such as the development of subsequent hematologic malignancy and overall survival. She also has an interest in the application of molecularly-targeted agents to the treatment of patients with hematologic malignancies.

Location

University of North Carolina at Chapel Hill: Chapel Hill, NC, USA

All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Marginal Zone Lymphoma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.